The effects of L-theanine supplementation on the outcomes of patients with mental disorders: a systematic review
Open accessThe DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
BACKGROUND: When utilized as an adjunct with antidepressants, antipsychotics, and other psychopharmacological drugs, certain amino acids, such as L-Theanine (LT), have shown potential effectiveness in enhancing the symptomatic outcomes of patients with mental disorders. Despite this, there is a lack of previous systematic reviews examining these associations. Therefore, we conducted a systematic review of randomized controlled trials examining these relationships. METHODS: A comprehensive systematic review was conducted, scouring six electronic databases (PubMed, Scopus, PsycINFO, Web of Science, CINAHL Complete, and Cochrane) from their inception up to June 2023, specifically focusing on randomized controlled trials that investigated the effects of LT supplementation on the outcomes of patients with mental health disorders. The Cochrane Risk of Bias Tool for Randomized Trials was employed to assess the quality of the included studies. RESULTS: Among the 419 publications identified, 11 studies from six countries - Israel, Iran, the USA, Japan, Australia, and Italy - were included in the final analysis. These studies covered a range of mental disorders, including schizophrenia, Attention-Deficit/Hyperactivity Disorder (ADHD), Obsessive-Compulsive Disorder (OCD), Major Depressive Disorder (MDD), sleep disorders, Generalized Anxiety Disorder (GAD), and Tourette syndrome. The findings demonstrated that LT supplementation reduced psychiatric symptoms more effectively than control conditions in individuals with schizophrenia, anxiety disorders, and ADHD. CONCLUSIONS: The findings from this systematic review suggest that LT supplementation significantly reduced psychiatric symptoms more effectively than control conditions in individuals with schizophrenia, anxiety disorders, and ADHD. However, further studies are essential to validate these findings, deepen the understanding of the observed effects, and explore the mechanisms underlying these associations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, there is currently insufficient evidence for L-theanine to be recommended as a standalone or adjunctive therapeutic intervention for chronic stress or any psychiatric conditions.”
From Effects of L-theanine on cognition, mood and sleep: evidence from human trials (2026) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“but there is insufficient evidence to recommend L-theanine as a treatment for any associated clinical symptoms (32, 39, 40, 44).”
From Effects of L-theanine on cognition, mood and sleep: evidence from human trials (2026) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, reviews of trials have consistently reported that this dose range appears to be safe and well-tolerated by participants, even over daily dosing for an extended period (13, 32, 39, 44, 45).”
From Effects of L-theanine on cognition, mood and sleep: evidence from human trials (2026) · cites this paper as [39]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Consistent with its use and availability as a dietary supplement, the current evidence suggests L-theanine supports individuals with associated health complaints (e.g. difficulties with sleep, or experiencing a stressful event)”
From Effects of L-theanine on cognition, mood and sleep: evidence from human trials (2026) · cites this paper as [39]
The cited source says what the claim attributes to it.
In the citing paper
“While there was evidence that L-theanine supplementation reduced psychiatric symptoms more than placebo in some randomized controlled trials involving individuals with schizophrenia, anxiety disorders, and ADHD, the authors stressed that caution is warranted in their interpretation, emphasizing the need for further well-designed trials to validate these preliminary findings (39).”
From Effects of L-theanine on cognition, mood and sleep: evidence from human trials (2026) · cites this paper as [39]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 34,787
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · Systematic Reviews · doi:10.1186/s13643-021-01626-4 · Cited by 13,874
Adverse effects of antipsychotic medications.
Muench, J., & Hamer, A. M. (2010) · PubMed · Cited by 582
Brisch, R., Saniotis, A., Wolf, R., Bielau, H., Bernstein, H.-G., Steiner, J., Bogerts, B., Braun, A. K., Jankowski, Z., Kumaritlake, J., et al. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00047 · Cited by 517
Leichsenring, F., Steinert, C., Rabung, S., & Ioannidis, J. P. A. (2022) · World Psychiatry · doi:10.1002/wps.20941 · Cited by 485
Benzodiazepines: Uses, Dangers, and Clinical Considerations
Edinoff, A. N., Nix, C. A., Hollier, J., Sagrera, C. E., Delacroix, B. M., Abubakar, T., Cornett, E. M., Kaye, A. M., & Kaye, A. D. (2021) · Neurology International · doi:10.3390/neurolint13040059 · Cited by 340
Alcázar, A., Ballesteros, O., Jurado, J. M., Pablos, F., Martín, M. J., Vilches, J. L., & Navalón, A. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf070601a · Cited by 250
Global Mental Health: Where We Are and Where We Are Going
Moitra, M., Owens, S., Hailemariam, M., Wilson, K. S., Mensa-Kwao, A., Gonese, G., Kamamia, C. K., White, B., Young, D. M., & Collins, P. Y. (2023) · Current Psychiatry Reports · doi:10.1007/s11920-023-01426-8 · Cited by 239
Yokogoshi, H., Kobayashi, M., Mochizuki, M., & Terashima, T. (1998) · Neurochemical Research · doi:10.1023/a:1022490806093 · Cited by 229
Cited by
Lee, K., Lee, D., Jeong, H., Kim, J.-Y., Shim, J. J., & Lee, J. H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189251 · Cited by 9
“This is a natural amino acid analog found in green tea and has been reported to regulate neurotransmitter levels and alleviate anxiety [40,41].”
Cavanah, A. M., Robinson, L. A., Mattingly, M. L., & Frugé, A. D. (2025) · Biomedicines · doi:10.3390/biomedicines13071656 · Cited by 7
“Along with glutamate, studies suggest L-theanine increases gamma-aminobutyric acid (GABA), crucial for the promotion of stress reduction and relaxation, as well as modulation of serotonin and dopamine [21].”
Lee, K., Lee, D., Kim, J.-Y., Shim, J. J., Bae, J. W., & Lee, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157317 · Cited by 5
“It can modulate neurotransmitter levels and alleviate anxiety, and thus has been used in stress and anxiety experiments [20,21].”
New and emerging treatments for anxiety disorders
Zbozinek, T. D., Khalsa, S. S., & Craske, M. G. (2026) · BMJ · doi:10.1136/bmj-2024-083441 · Cited by 4
Perrotta, C., Carnovale, C., Pozzi, M., Palma, C. D., Cervia, D., Nobile, M., & Clementi, E. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100061 · Cited by 4
Metadata
- Authors
- Moshfeghinia, R., Sanaei, E., Mostafavi, S., Assadian, K., Sanaei, A., & Ayano, G.
- Affiliations
- Shiraz University of Medical Sciences (IR)
- Shahid Sadoughi University of Medical Sciences and Health Services (IR)
- Curtin University (AU)
- Corresponding author
- Moshfeghinia, Reza
- Venue
- BMC Psychiatry
- Published
- 2024-12-04
- Volume
- 24
- Issue
- 1
- Pages
- 886-886
- ISSN
- 1471-244X (ISSN-L)
- PMC
- PMC11616108
- OpenAlex
- W4405008889
- Cited by
- 17
- References
- 69
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 1
- FWCI
- 0.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- BMC Psychiatry (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- theanine, dietary supplementation, mental illness, schizophrenia, attention deficit hyperactivity disorder, obsessive-compulsive disorder, major depressive disorder, generalized anxiety disorder, Tourette syndrome, sleep disorders, anxiety disorders, psychiatric symptoms
- MeSH terms
- Mental Disorders, Glutamates, Humans, Randomized Controlled Trials as Topic, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effects of L-theanine supplementation on the outcomes of patients with mental disorders: a systematic review. https://app.cochat.ai/papers/10.1186/s12888-024-06285-y
- The paper
- Moshfeghinia, R., Sanaei, E., Mostafavi, S., Assadian, K., Sanaei, A., & Ayano, G. (2024). The effects of L-theanine supplementation on the outcomes of patients with mental disorders: a systematic review. BMC Psychiatry. https://doi.org/10.1186/s12888-024-06285-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
